लोड हो रहा है...
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B‐cell‐targeted therapies
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, and one of the most common causes of disability in young adults. Over the last decade, new disease‐modifying therapies have emerged, including monoclonal antibodies (mAbs) that provide highly targeted therapies with greater effica...
में बचाया:
| में प्रकाशित: | Br J Pharmacol |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5466523/ https://ncbi.nlm.nih.gov/pubmed/28319650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13780 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|